MMR vaccine
The MMR vaccine is a vaccine against measles, mumps, and rubella (German measles).
MMR vaccine
| |
Combination of | |
Measles vaccine | Vaccine |
Mumps vaccine | Vaccine |
Rubella vaccine | Vaccine |
Identifiers | |
CAS number | ? |
ATC code | J07BD52 |
PubChem | ? |
ChemSpider | none |
Therapeutic considerations | |
Pregnancy cat. |
? |
Legal status |
℞ Prescription only |
Routes | ? |
The first dose is given to children around 9 to 15 months of age, with a second dose at 15 months to 6 years of age, with at least 4 weeks between the doses.[1][2] After two doses 97% of people are protected against measles, 88% against mumps, and at least 97% against rubella.[1]
The vaccine is also recommended in those who do not have evidence of immunity,[1] and those with well controlled HIV/AIDS.[3][4] It is given by injection.[1]
MMR Vaccine Media
Measles cases reported in the United States fell drastically after introduction of the measles vaccine.
Maurice Hilleman, who developed the MMR vaccine
References
- ↑ 1.0 1.1 1.2 1.3 "MMR Vaccination What You Should Know Measles, Mumps, Rubella". CDC. 2 February 2018. Retrieved 10 September 2018.
- ↑ "Measles vaccines: WHO position paper – April 2017". Releve Epidemiologique Hebdomadaire. 92 (17): 205–27. 28 April 2017. PMID 28459148.
- ↑ Kinney, Rebecca (2 May 2017). "Core Concepts - Immunizations in Adults - Basic HIV Primary Care - National HIV CurriculumImmunizations in Adults". www.hiv.uw.edu.
- ↑ Watson, JC; Hadler, SC; Dykewicz, CA; Reef, S; Phillips, L (22 May 1998). "Measles, mumps, and rubella--vaccine use and strategies for elimination of measles, rubella, and congenital rubella syndrome and control of mumps: recommendations of the Advisory Committee on Immunization Practices (ACIP)". MMWR. Recommendations and Reports : Morbidity and Mortality Weekly Report. Recommendations and Reports. 47 (RR-8): 1–57. PMID 9639369.